The SecureSeal octyl topical skin adhesive is the newest addition to the Cardinal Health topical skin adhesive portfolio. Clinical indications for SecureSeal include wounds that are less than six hours old, clean and straight wounds, deep wounds where a suitable layer of deep-layer sutures have been applied, flap wounds and facial wounds.
Cardinal Health said use of the new adhesive it is appropriate for use across clinical settings, including the operating room, emergency room, cath labs, surgery centers, urgent care centers and in physicians’ offices.
“We understand that our customers appreciate the unique characteristics of both octyl and butyl topical skin adhesives,” said Lisa Ashby, president of category management at Cardinal Health, in the release, “so it’s important that we have a complete offering that can meet our customers’ needs.”
Cardinal Health is headquartered in Dublin, Ohio.
Related Articles on New Technology:
Sotera Wireless Received FDA Clearance of Vital Signs Monitoring System
Sony Set to Launch 3D Camcorder for Operating Microscopes
Spacelabs Receives FDA Clearance for Sidestream Capnography Module
